Detalles de la búsqueda
1.
Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.
J Virol
; 88(9): 5100-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24574396
2.
Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.
Microb Pathog
; 55: 9-15, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23247146
3.
Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.
J Infect Dis
; 206(4): 512-22, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22693229
4.
Increasing the time of exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously.
J Infect Dis
; 204(3): 426-32, 2011 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21742842
5.
Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
J Infect Dis
; 204 Suppl 1: S549-58, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21666212
6.
Correction for Kim et al., development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model.
J Virol
; 89(9): 5193, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25841050
7.
Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants.
Vaccine
; 38(2): 101-106, 2020 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31706809
8.
Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9-12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial.
Vaccine X
; 6: 100074, 2020 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33005887
9.
Measles Maternal Antibodies With Low Avidity Do Not Interfere With the Establishment of Robust Quantity and Quality Antibody Responses After the Primary Dose of Measles, Mumps, and Rubella Vaccine Administered at 12-Months of Age.
J Pediatric Infect Dis Soc
; 9(6): 752-755, 2020 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31644795
10.
Development of a high-throughput assay to measure measles neutralizing antibodies.
PLoS One
; 14(8): e0220780, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31415584
11.
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants.
Clin Infect Dis
; 45(11): 1417-24, 2007 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17990222
12.
Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop.
Vaccine
; 34(41): 4843-4849, 2016 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566900
13.
Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein.
Clin Vaccine Immunol
; 21(3): 383-90, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24403526
14.
ELISA underestimates measles antibody seroprevalence in US military recruits.
Vaccine
; 26(38): 4877-8, 2008 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-18586062
15.
Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity.
J Virol
; 81(1): 261-71, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17050595
16.
Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
Pediatrics
; 119(3): e574-9, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17332177
17.
Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
J Infect Dis
; 196(3): 347-55, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17597448
18.
Measles-virus-neutralizing antibodies in intravenous immunoglobulins.
J Infect Dis
; 194(6): 781-9, 2006 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16941344
19.
Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Vaccine
; 24(5): 683-90, 2006 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-16154241
20.
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.
J Virol
; 80(10): 5032-40, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16641294